BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mattar P, Bieback K. Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells. Front Immunol 2015;6:560. [PMID: 26579133 DOI: 10.3389/fimmu.2015.00560] [Cited by in Crossref: 138] [Cited by in F6Publishing: 132] [Article Influence: 19.7] [Reference Citation Analysis]
Number Citing Articles
1 Kieling CO, Uribe-Cruz C, López ML, Osvaldt AB, da Silveira TR, Matte U. Paracrine Effects of Bone Marrow Mononuclear Cells in Survival and Cytokine Expression after 90% Partial Hepatectomy. Stem Cells Int 2017;2017:5270527. [PMID: 28326105 DOI: 10.1155/2017/5270527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Girdlestone J. Mesenchymal stromal cells with enhanced therapeutic properties. Immunotherapy 2016;8:1405-16. [DOI: 10.2217/imt-2016-0098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
3 Pandey V, Madi S, Gupta P. The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells? Journal of Clinical Orthopaedics and Trauma 2022;26:101804. [DOI: 10.1016/j.jcot.2022.101804] [Reference Citation Analysis]
4 Toosi S, Behravan J. Osteogenesis and bone remodeling: A focus on growth factors and bioactive peptides. Biofactors 2020;46:326-40. [PMID: 31854489 DOI: 10.1002/biof.1598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
5 Nielsen EØ, Chen L, Hansen JO, Degn M, Overgaard S, Ding M. Optimizing Osteogenic Differentiation of Ovine Adipose-Derived Stem Cells by Osteogenic Induction Medium and FGFb, BMP2, or NELL1 In Vitro. Stem Cells Int 2018;2018:9781393. [PMID: 30356449 DOI: 10.1155/2018/9781393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Chen CP, Wang LK, Chen CY, Chen CY, Wu YH. Placental multipotent mesenchymal stromal cell-derived Slit2 may regulate macrophage motility during placental infection. Mol Hum Reprod 2021;27:gaaa076. [PMID: 33275139 DOI: 10.1093/molehr/gaaa076] [Reference Citation Analysis]
7 Laroye C, Gibot S, Reppel L, Bensoussan D. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock? Stem Cells 2017;35:2331-9. [PMID: 28856759 DOI: 10.1002/stem.2695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
8 Rovira J, Diekmann F, Campistol JM, Ramírez-Bajo MJ. Therapeutic application of extracellular vesicles in acute and chronic renal injury. Nefrologia 2017;37:126-37. [PMID: 27462016 DOI: 10.1016/j.nefro.2016.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cheng A, Choi D, Lora M, Shum-Tim D, Rak J, Colmegna I. Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo. Stem Cell Res Ther 2020;11:539. [PMID: 33317598 DOI: 10.1186/s13287-020-02050-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zulpaite R, Miknevicius P, Leber B, Strupas K, Stiegler P, Schemmer P. Ex-vivo Kidney Machine Perfusion: Therapeutic Potential. Front Med (Lausanne) 2021;8:808719. [PMID: 35004787 DOI: 10.3389/fmed.2021.808719] [Reference Citation Analysis]
11 Yeo WS, Ng QX. Biomarkers of immune tolerance in kidney transplantation: an overview. Pediatr Nephrol 2021. [PMID: 33712863 DOI: 10.1007/s00467-021-05023-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Özdemir AT, Özgül Özdemir RB, Kırmaz C, Sarıboyacı AE, Ünal Halbutoğlları ZS, Özel C, Karaöz E. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol 2016;310:108-15. [PMID: 27576175 DOI: 10.1016/j.cellimm.2016.08.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
13 Hyldig K, Riis S, Pennisi CP, Zachar V, Fink T. Implications of Extracellular Matrix Production by Adipose Tissue-Derived Stem Cells for Development of Wound Healing Therapies. Int J Mol Sci 2017;18:E1167. [PMID: 28561757 DOI: 10.3390/ijms18061167] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
14 Chen C, Qu Z, Yin X, Shang C, Ao Q, Gu Y, Liu Y. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study. Mol Med Rep 2016;14:4209-15. [PMID: 27634376 DOI: 10.3892/mmr.2016.5745] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
15 Itakura G, Ozaki M, Nagoshi N, Kawabata S, Nishiyama Y, Sugai K, Iida T, Kashiwagi R, Ookubo T, Yastake K, Matsubayashi K, Kohyama J, Iwanami A, Matsumoto M, Nakamura M, Okano H. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells. Sci Rep 2017;7:12996. [PMID: 29021610 DOI: 10.1038/s41598-017-13522-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
16 Ciavarella C, Pasquinelli G. The Dual Nature of Mesenchymal Stem Cells (MSCs): Yin and Yang of the Inflammatory Process. In: Ahmed Al-anazi K, editor. Update on Mesenchymal and Induced Pluripotent Stem Cells. IntechOpen; 2020. [DOI: 10.5772/intechopen.82877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Qi L, Wu J, Zhu S, Wang X, Lv X, Liu C, Liu YJ, Chen J. Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease Via Tr1 Cells. Stem Cell Rev Rep 2022. [PMID: 35274217 DOI: 10.1007/s12015-022-10353-9] [Reference Citation Analysis]
18 Christy BA, Herzig MC, Delavan C, Cantu C, Salgado C, Bynum JA, Cap AP. Human primary fibroblasts perform similarly to MSCs in assays used to evaluate MSC safety and potency. Transfusion 2019;59:1593-600. [PMID: 30980752 DOI: 10.1111/trf.15187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Khan K, Makhoul G, Yu B, Jalani G, Derish I, Rutman AK, Cerruti M, Schwertani A, Cecere R. Amniotic stromal stem cell-loaded hydrogel repairs cardiac tissue in infarcted rat hearts via paracrine mediators. J Tissue Eng Regen Med 2021. [PMID: 34726328 DOI: 10.1002/term.3262] [Reference Citation Analysis]
20 Silva-Cote I, Cruz-Barrera M, Cañas-Arboleda M, Correa-Araujo L, Méndez L, Jagielska J, Camacho B, Salguero G. Strategy for the Generation of Engineered Bone Constructs Based on Umbilical Cord Mesenchymal Stromal Cells Expanded with Human Platelet Lysate. Stem Cells Int 2019;2019:7198215. [PMID: 31885622 DOI: 10.1155/2019/7198215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712. [PMID: 31730279 DOI: 10.1111/cpr.12712] [Cited by in Crossref: 49] [Cited by in F6Publishing: 67] [Article Influence: 16.3] [Reference Citation Analysis]
22 He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, Han Q, Zhao RC, Wang L, Zhang F. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis 2021;12:2040622321993442. [PMID: 33633826 DOI: 10.1177/2040622321993442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Guo S, Huang C, Han F, Chen B, Ding Y, Zhao Y, Chen Z, Wen S, Wang M, Shen B, Zhu W. Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth. Stem Cells Int 2021;2021:9989790. [PMID: 34306099 DOI: 10.1155/2021/9989790] [Reference Citation Analysis]
24 Yu J, Hao G, Wang D, Liu J, Dong X, Sun Y, Pan Q, Li Y, Shi X, Li L, Cao H. Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats. Stem Cells Int. 2017;2017:1798260. [PMID: 28491093 DOI: 10.1155/2017/1798260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
25 Scalea JR, Tomita Y, Lindholm CR, Burlingham W. Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms. Front Immunol 2016;7:87. [PMID: 27014267 DOI: 10.3389/fimmu.2016.00087] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
26 Voisin C, Cauchois G, Reppel L, Laroye C, Louarn L, Schenowitz C, Sonon P, Poras I, Wang V, D Carosella E, Benkirane-Jessel N, Moreau P, Rouas-Freiss N, Bensoussan D, Huselstein C. Are the Immune Properties of Mesenchymal Stem Cells from Wharton's Jelly Maintained during Chondrogenic Differentiation? J Clin Med 2020;9:E423. [PMID: 32033151 DOI: 10.3390/jcm9020423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, Noël D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U, Jorgensen C; ADIPOA Consortium. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl Med 2016;5:847-56. [PMID: 27217345 DOI: 10.5966/sctm.2015-0245] [Cited by in Crossref: 233] [Cited by in F6Publishing: 201] [Article Influence: 38.8] [Reference Citation Analysis]
28 Pleyer L, Valent P, Greil R. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci 2016;17:E1009. [PMID: 27355944 DOI: 10.3390/ijms17071009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
29 Rendra E, Scaccia E, Bieback K. Recent advances in understanding mesenchymal stromal cells. F1000Res 2020;9:F1000 Faculty Rev-156. [PMID: 32148780 DOI: 10.12688/f1000research.21862.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
30 Robb KP, Fitzgerald JC, Barry F, Viswanathan S. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency. Cytotherapy. 2019;21:289-306. [PMID: 30528726 DOI: 10.1016/j.jcyt.2018.10.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
31 Hackstein H, Tschipakow I, Bein G, Nold P, Brendel C, Baal N. Contact-dependent abrogation of bone marrow-derived plasmacytoid dendritic cell differentiation by murine mesenchymal stem cells. Biochem Biophys Res Commun 2016;476:15-20. [PMID: 27233615 DOI: 10.1016/j.bbrc.2016.05.108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
32 Nielsen FM, Riis SE, Andersen JI, Lesage R, Fink T, Pennisi CP, Zachar V. Discrete adipose-derived stem cell subpopulations may display differential functionality after in vitro expansion despite convergence to a common phenotype distribution. Stem Cell Res Ther 2016;7:177. [PMID: 27906060 DOI: 10.1186/s13287-016-0435-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
33 Kim KH, Park TS, Cho BW, Kim TM. Nanoparticles from Equine Fetal Bone Marrow-Derived Cells Enhance the Survival of Injured Chondrocytes. Animals (Basel) 2020;10:E1723. [PMID: 32977476 DOI: 10.3390/ani10101723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Torres Crigna A, Daniele C, Gamez C, Medina Balbuena S, Pastene DO, Nardozi D, Brenna C, Yard B, Gretz N, Bieback K. Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. Front Med (Lausanne) 2018;5:179. [PMID: 29963554 DOI: 10.3389/fmed.2018.00179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
35 Nicotra T, Desnos A, Halimi J, Antonot H, Reppel L, Belmas T, Freton A, Stranieri F, Mebarki M, Larghero J, Cras A, Faivre L. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1). Stem Cell Res Ther 2020;11:426. [PMID: 33004063 DOI: 10.1186/s13287-020-01947-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Horie S, Gonzalez H, Brady J, Devaney J, Scully M, O'Toole D, Laffey JG. Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury. Int J Mol Sci 2021;22:12842. [PMID: 34884645 DOI: 10.3390/ijms222312842] [Reference Citation Analysis]
37 Winters AA, Bou-ghannam S, Thorp H, Hawayek JA, Atkinson DL, Bartlett CE, Silva FJ, Hsu EW, Moreno AP, Grainger DA, Patel AN. Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease. Cell Transplant 2016;25:1591-607. [DOI: 10.3727/096368916x691501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Maughon TS, Shen X, Huang D, Michael AOA, Shockey WA, Andrews SH, McRae JM 3rd, Platt MO, Fernández FM, Edison AS, Stice SL, Marklein RA. Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression. Cytotherapy 2021:S1465-3249(21)00775-1. [PMID: 34696960 DOI: 10.1016/j.jcyt.2021.08.002] [Reference Citation Analysis]
39 Dymowska M, Aksamit A, Zielniok K, Kniotek M, Kaleta B, Roszczyk A, Zych M, Dabrowski F, Paczek L, Burdzinska A. Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton's Jelly-A Comparative Study. Pharmaceutics 2021;13:1822. [PMID: 34834238 DOI: 10.3390/pharmaceutics13111822] [Reference Citation Analysis]
40 Kizilay Mancini Ö, Lora M, Shum-Tim D, Nadeau S, Rodier F, Colmegna I. A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis. Stem Cells Transl Med 2017;6:1132-40. [PMID: 28194905 DOI: 10.1002/sctm.16-0221] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
41 Alunno A, Bistoni O, Montanucci P, Basta G, Calafiore R, Gerli R. Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact. Ann Rheum Dis 2018;77:e14. [PMID: 28611081 DOI: 10.1136/annrheumdis-2017-211790] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
42 Pool MBF, Vos J, Eijken M, van Pel M, Reinders MEJ, Ploeg RJ, Hoogduijn MJ, Jespersen B, Leuvenink HGD, Moers C. Treating Ischemically Damaged Porcine Kidneys with Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells During Ex Vivo Normothermic Machine Perfusion. Stem Cells Dev 2020;29:1320-30. [PMID: 32772797 DOI: 10.1089/scd.2020.0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant 2020;55:48-61. [PMID: 31089283 DOI: 10.1038/s41409-019-0546-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
44 Torres Crigna A, Uhlig S, Elvers-Hornung S, Klüter H, Bieback K. Human Adipose Tissue-Derived Stromal Cells Suppress Human, but Not Murine Lymphocyte Proliferation, via Indoleamine 2,3-Dioxygenase Activity. Cells 2020;9:E2419. [PMID: 33167329 DOI: 10.3390/cells9112419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Lohmann S, Pool MBF, Rozenberg KM, Keller AK, Moers C, Møldrup U, Møller BK, Lignell SJM, Krag S, Sierra-Parraga JM, Lo Faro ML, Hunter J, Hoogduijn MJ, Baan CC, Leuvenink HGD, Ploeg RJ, Eijken M, Jespersen B. Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: A porcine renal autotransplantation study. Am J Transplant 2021;21:2348-59. [PMID: 33382194 DOI: 10.1111/ajt.16473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Khan RS, Newsome PN. A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells. Front Immunol 2019;10:1952. [PMID: 31555259 DOI: 10.3389/fimmu.2019.01952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
47 Oh JY, Kim E, Yun YI, Lee RH. Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials. Ocul Surf 2021;20:185-94. [PMID: 33607323 DOI: 10.1016/j.jtos.2021.02.002] [Reference Citation Analysis]
48 Trivisonno A, Nachira D, Boškoski I, Porziella V, Di Rocco G, Baldari S, Toietta G. Regenerative medicine approaches for the management of respiratory tract fistulas. Stem Cell Res Ther 2020;11:451. [PMID: 33097096 DOI: 10.1186/s13287-020-01968-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Yilmaz A, Aslan MT, İnce Z, Vural M. Mesenchymal Stem Cell Therapy in a Preterm Infant with Bronchopulmonary Dysplasia. Indian J Pediatr 2021;88:1262. [PMID: 34436738 DOI: 10.1007/s12098-021-03946-8] [Reference Citation Analysis]
50 Oh JY, Lee RH. Mesenchymal stromal cells for the treatment of ocular autoimmune diseases. Prog Retin Eye Res 2021;:100967. [PMID: 33775824 DOI: 10.1016/j.preteyeres.2021.100967] [Reference Citation Analysis]
51 Wilson A, Hodgson-Garms M, Frith JE, Genever P. Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy. Front Immunol 2019;10:1112. [PMID: 31164890 DOI: 10.3389/fimmu.2019.01112] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
52 Doster DL, Jensen AR, Khaneki S, Markel TA. Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit. Cytotherapy 2016;18:1457-70. [PMID: 27745788 DOI: 10.1016/j.jcyt.2016.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
53 Mijiritsky E, Gardin C, Ferroni L, Lacza Z, Zavan B. Albumin-impregnated bone granules modulate the interactions between mesenchymal stem cells and monocytes under in vitro inflammatory conditions. Mater Sci Eng C Mater Biol Appl 2020;110:110678. [PMID: 32204105 DOI: 10.1016/j.msec.2020.110678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Tynecka M, Moniuszko M, Eljaszewicz A. Old Friends with Unexploited Perspectives: Current Advances in Mesenchymal Stem Cell-Based Therapies in Asthma. Stem Cell Rev Rep 2021;17:1323-42. [PMID: 33649900 DOI: 10.1007/s12015-021-10137-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Salcedo-Jiménez R, Koenig JB, Lee OJ, Gibson TWG, Madan P, Koch TG. Extracorporeal Shock Wave Therapy Enhances the In Vitro Metabolic Activity and Differentiation of Equine Umbilical Cord Blood Mesenchymal Stromal Cells. Front Vet Sci 2020;7:554306. [PMID: 33344521 DOI: 10.3389/fvets.2020.554306] [Reference Citation Analysis]
56 Topcu Sarica L, Zibandeh N, Genç D, Gül F, Akkoç T, Kombak EF, Cinel L, Akkoç T, Cinel I. Immunomodulatory and Tissue-preserving Effects of Human Dental Follicle Stem Cells in a Rat Cecal Ligation and Perforation Sepsis Model. Arch Med Res 2020;51:397-405. [PMID: 32334851 DOI: 10.1016/j.arcmed.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Bispo DSC, Jesus CSH, Correia M, Ferreira F, Bonifazio G, Goodfellow BJ, Oliveira MB, Mano JF, Gil AM. NMR Metabolomics Assessment of Osteogenic Differentiation of Adipose-Tissue-Derived Mesenchymal Stem Cells. J Proteome Res . [DOI: 10.1021/acs.jproteome.1c00832] [Reference Citation Analysis]
58 Boieri M, Shah P, Dressel R, Inngjerdingen M. The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview. Front Immunol. 2016;7:333. [PMID: 27625651 DOI: 10.3389/fimmu.2016.00333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
59 Maria AT, Toupet K, Maumus M, Fonteneau G, Le Quellec A, Jorgensen C, Guilpain P, Noël D. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J Autoimmun 2016;70:31-9. [PMID: 27052182 DOI: 10.1016/j.jaut.2016.03.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
60 Sherman LS, Condé-Green A, Kotamarti VS, Lee ES, Rameshwar P. Enzyme-Free Isolation of Adipose-Derived Mesenchymal Stem Cells. Methods Mol Biol 2018;1842:203-6. [PMID: 30196411 DOI: 10.1007/978-1-4939-8697-2_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
61 Skalska U, Kuca-Warnawin E, Kornatka A, Janicka I, Musiałowicz U, Burakowski T, Kontny E. Articular and subcutaneous adipose tissues of rheumatoid arthritis patients represent equal sources of immunoregulatory mesenchymal stem cells. Autoimmunity 2017;50:441-50. [PMID: 29212384 DOI: 10.1080/08916934.2017.1411481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
62 Mrahleh MA, Matar S, Jafar H, Wehaibi S, Aslam N, Awidi A. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients. Front Immunol 2021;12:732549. [PMID: 34650558 DOI: 10.3389/fimmu.2021.732549] [Reference Citation Analysis]
63 Faghih H, Javeri A, Taha MF. Impact of early subcultures on stemness, migration and angiogenic potential of adipose tissue-derived stem cells and their resistance to in vitro ischemic condition. Cytotechnology 2017;69:885-900. [PMID: 28536871 DOI: 10.1007/s10616-017-0104-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
64 Morena F, Argentati C, Calzoni E, Cordellini M, Emiliani C, D'Angelo F, Martino S. Ex-Vivo Tissues Engineering Modeling for Reconstructive Surgery Using Human Adult Adipose Stem Cells and Polymeric Nanostructured Matrix. Nanomaterials (Basel) 2016;6:E57. [PMID: 28335186 DOI: 10.3390/nano6040057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
65 Ahangar P, Mills SJ, Cowin AJ. Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair. Int J Mol Sci 2020;21:E7038. [PMID: 32987830 DOI: 10.3390/ijms21197038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
66 McLeod CM, Mauck RL. On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis. Eur Cell Mater. 2017;34:217-231. [PMID: 29076514 DOI: 10.22203/ecm.v034a14] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 17.4] [Reference Citation Analysis]
67 Vellosillo L, Pascual-guerra J, Muñoz MP, Rodríguez-navarro JA, González-nieto D, Barrio LC, Lobo MDVT, Paíno CL. Oligodendroglia Generated From Adult Rat Adipose Tissue by Direct Cell Conversion. Front Cell Dev Biol 2022;10:741499. [DOI: 10.3389/fcell.2022.741499] [Reference Citation Analysis]
68 Martínez-Aguilar R, Romero-Pinedo S, Ruiz-Magaña MJ, Olivares EG, Ruiz-Ruiz C, Abadía-Molina AC. Menstrual blood-derived stromal cells modulate functional properties of mouse and human macrophages. Sci Rep 2020;10:21389. [PMID: 33288796 DOI: 10.1038/s41598-020-78423-x] [Reference Citation Analysis]
69 Pool M, Leuvenink H, Moers C. Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation? Int J Mol Sci. 2019;20:4614. [PMID: 31540361 DOI: 10.3390/ijms20184614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
70 Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine. Stem Cells Transl Med. 2017;6:2173-2185. [PMID: 29076267 DOI: 10.1002/sctm.17-0129] [Cited by in Crossref: 242] [Cited by in F6Publishing: 251] [Article Influence: 48.4] [Reference Citation Analysis]
71 Fathi E, Sanaat Z, Farahzadi R. Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts. Blood Res 2019;54:165-74. [PMID: 31730689 DOI: 10.5045/br.2019.54.3.165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
72 Ménard C, Dulong J, Roulois D, Hébraud B, Verdière L, Pangault C, Sibut V, Bezier I, Bescher N, Monvoisin C, Gadelorge M, Bertheuil N, Flécher E, Casteilla L, Collas P, Sensebé L, Bourin P, Espagnolle N, Tarte K. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells 2020;38:146-59. [PMID: 31502731 DOI: 10.1002/stem.3077] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
73 Świątkowska-Flis B, Zdolińska-Malinowska I, Sługocka D, Boruczkowski D. The use of umbilical cord-derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real-life settings. Stem Cells Transl Med 2021. [PMID: 34313400 DOI: 10.1002/sctm.21-0027] [Reference Citation Analysis]
74 Nitkin CR, Bonfield TL. Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements. Stem Cells Transl Med 2017;6:539-65. [PMID: 28191766 DOI: 10.5966/sctm.2015-0427] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
75 Farhang N, Brunger JM, Stover JD, Thakore PI, Lawrence B, Guilak F, Gersbach CA, Setton LA, Bowles RD. * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments. Tissue Eng Part A 2017;23:738-49. [PMID: 28095751 DOI: 10.1089/ten.TEA.2016.0441] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
76 Sagar R, Walther-Jallow L, David AL, Götherström C, Westgren M. Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. Curr Stem Cell Rep 2018;4:61-8. [PMID: 29600162 DOI: 10.1007/s40778-018-0118-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
77 Mallis P, Boulari D, Michalopoulos E, Dinou A, Spyropoulou-Vlachou M, Stavropoulos-Giokas C. Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton's Jelly Tissue. Bioengineering (Basel). 2018;5:95. [PMID: 30388848 DOI: 10.3390/bioengineering5040095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
78 Lopez-Santalla M, Fernandez-Perez R, Garin MI. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications. Cells 2020;9:E1852. [PMID: 32784608 DOI: 10.3390/cells9081852] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
79 Wang X, Li G, Guo J, Yang L, Liu Y, Sun Q, Li R, Yu W. Hybrid composites of mesenchymal stem cell sheets, hydroxyapatite, and platelet-rich fibrin granules for bone regeneration in a rabbit calvarial critical-size defect model. Exp Ther Med 2017;13:1891-9. [PMID: 28565782 DOI: 10.3892/etm.2017.4199] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
80 Vladimirovna IL, Sosunova E, Nikolaev A, Nenasheva T. Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation. J Immunol Res 2016;2016:7121580. [PMID: 27529074 DOI: 10.1155/2016/7121580] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
81 El-Jawhari JJ, El-Sherbiny Y, McGonagle D, Jones E. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors? Front Immunol 2021;12:643170. [PMID: 33732263 DOI: 10.3389/fimmu.2021.643170] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Yigitbilek F, Conley SM, Tang H, Saadiq IM, Jordan KL, Lerman LO, Taner T. Comparable in vitro Function of Human Liver-Derived and Adipose Tissue-Derived Mesenchymal Stromal Cells: Implications for Cell-Based Therapy. Front Cell Dev Biol 2021;9:641792. [PMID: 33842466 DOI: 10.3389/fcell.2021.641792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Lepage SIM, Lee OJ, Koch TG. Equine Cord Blood Mesenchymal Stromal Cells Have Greater Differentiation and Similar Immunosuppressive Potential to Cord Tissue Mesenchymal Stromal Cells. Stem Cells Dev 2019;28:227-37. [PMID: 30484372 DOI: 10.1089/scd.2018.0135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
84 O'Donnell BT, Al-Ghadban S, Ives CJ, L'Ecuyer MP, Monjure TA, Romero-Lopez M, Li Z, Goodman SB, Lin H, Tuan RS, Bunnell BA. Adipose Tissue-Derived Stem Cells Retain Their Adipocyte Differentiation Potential in Three-Dimensional Hydrogels and Bioreactors . Biomolecules 2020;10:E1070. [PMID: 32709032 DOI: 10.3390/biom10071070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Meesuk L, Tantrawatpan C, Kheolamai P, Manochantr S. The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow. Biochem Biophys Rep 2016;8:34-40. [PMID: 28955939 DOI: 10.1016/j.bbrep.2016.07.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
86 Seo E, Kang H, Lim OK, Jun HS. Supplementation with IL-6 and Muscle Cell Culture Conditioned Media Enhances Myogenic Differentiation of Adipose Tissue-Derived Stem Cells through STAT3 Activation. Int J Mol Sci 2018;19:E1557. [PMID: 29882916 DOI: 10.3390/ijms19061557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
87 Quaranta P, Focosi D, Freer G, Pistello M. Tweaking Mesenchymal Stem/Progenitor Cell Immunomodulatory Properties with Viral Vectors Delivering Cytokines. Stem Cells Dev 2016;25:1321-41. [PMID: 27476883 DOI: 10.1089/scd.2016.0145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
88 Jacobs FA, van de Vyver M, Ferris WF. Isolation and Characterization of Different Mesenchymal Stem Cell Populations from Rat Femur. In: Guest PC, editor. Pre-Clinical Models. New York: Springer; 2019. pp. 133-47. [DOI: 10.1007/978-1-4939-8994-2_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
89 Villatoro AJ, Fernández V, Claros S, Alcoholado C, Cifuentes M, Merayo-Lloves J, Andrades JA, Becerra J. Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy. Int J Mol Sci 2017;18:E2264. [PMID: 29143779 DOI: 10.3390/ijms18112264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
90 Guillén MI, Platas J, Pérez Del Caz MD, Mirabet V, Alcaraz MJ. Paracrine Anti-inflammatory Effects of Adipose Tissue-Derived Mesenchymal Stem Cells in Human Monocytes. Front Physiol 2018;9:661. [PMID: 29904354 DOI: 10.3389/fphys.2018.00661] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
91 Yin C, Liang Y, Zhang J, Ruan G, Li Z, Pang R, Pan X. Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hindlimb Ischemia through Enhancing Angiogenesis in Tree Shrews. Stem Cells Int 2016;2016:9742034. [PMID: 27651800 DOI: 10.1155/2016/9742034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
92 Shafiee A, Patel J, Lee JS, Hutmacher DW, Fisk NM, Khosrotehrani K. Mesenchymal stem/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts. Sci Rep. 2017;7:13558. [PMID: 29051567 DOI: 10.1038/s41598-017-13971-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
93 Zhang Z, Huang S, Wu S, Qi J, Li W, Liu S, Cong Y, Chen H, Lu L, Shi S, Wang D, Chen W, Sun L. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. EBioMedicine 2019;45:341-50. [PMID: 31248835 DOI: 10.1016/j.ebiom.2019.06.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
94 Zhang Y, Zhang J, Yi H, Zheng J, Cai J, Chen W, Lu T, Chen L, Du C, Liu J, Yao J, Zhao H, Wang G, Fu B, Zhang T, Zhang J, Wang G, Li H, Xiang AP, Chen G, Yi S, Zhang Q, Yang Y. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial. Stem Cell Res Ther 2021;12:244. [PMID: 33863383 DOI: 10.1186/s13287-021-02246-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Calcat-I-Cervera S, Sanz-Nogués C, O'Brien T. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. Front Med (Lausanne) 2021;8:728496. [PMID: 34616756 DOI: 10.3389/fmed.2021.728496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Svitina H, Kyryk V, Skrypkina I, Kuchma M, Bukreieva T, Areshkov P, Shablii Y, Denis Y, Klymenko P, Garmanchuk L, Ostapchenko L, Lobintseva G, Shablii V. Placenta-derived multipotent cells have no effect on the size and number of DMH-induced colon tumors in rats. Exp Ther Med 2017;14:2135-47. [PMID: 28962134 DOI: 10.3892/etm.2017.4792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
97 Vellosillo L, Muñoz MP, Paíno CL. Adipose tissue-derived stromal cells (ADSC) express oligodendrocyte and myelin markers, but they do not function as oligodendrocytes. Histochem Cell Biol 2017;148:503-15. [PMID: 28620864 DOI: 10.1007/s00418-017-1588-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
98 Carmona MD, Cañadillas S, Romero M, Blanco A, Nogueras S, Herrera C. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy. Cytotherapy 2017;19:947-61. [PMID: 28673775 DOI: 10.1016/j.jcyt.2017.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
99 Hoang VT, Trinh QM, Phuong DTM, Bui HTH, Hang LM, Ngan NTH, Anh NTT, Nhi PY, Nhung TTH, Lien HT, Nguyen TD, Thanh LN, Hoang DM. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources. Cytotherapy 2021;23:88-99. [PMID: 33097415 DOI: 10.1016/j.jcyt.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
100 Namba F. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia. Pediatr Int. 2019;61:945-950. [PMID: 31487104 DOI: 10.1111/ped.14001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
101 Teunissen M, Verseijden F, Riemers FM, van Osch GJVM, Tryfonidou MA. The lower in vitro chondrogenic potential of canine adipose tissue-derived mesenchymal stromal cells (MSC) compared to bone marrow-derived MSC is not improved by BMP-2 or BMP-6. Vet J 2021;269:105605. [PMID: 33593496 DOI: 10.1016/j.tvjl.2020.105605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
102 Ramhormozi P, Mohajer Ansari J, Simorgh S, Nobakht M. Bone Marrow-Derived Mesenchymal Stem Cells Combined With Simvastatin Accelerates Burn Wound Healing by Activation of the Akt/mTOR Pathway. J Burn Care Res 2020;41:1069-78. [PMID: 32157277 DOI: 10.1093/jbcr/iraa005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Murphy N, Lynch K, Lohan P, Treacy O, Ritter T. Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation. Curr Opin Organ Transplant 2016;21:559-67. [PMID: 27801687 DOI: 10.1097/MOT.0000000000000360] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
104 Xu C, Diao Y, Wang J, Liang J, Xu H, Zhao M, Zheng B, Luan Z, Wang J, Yang X, Wei M, Duan J, Wang K, Chen C, Chen F, Ming D, Zhang S, Sun H, Li X. Intravenously Infusing the Secretome of Adipose-Derived Mesenchymal Stem Cells Ameliorates Neuroinflammation and Neurological Functioning After Traumatic Brain Injury. Stem Cells and Development 2020;29:222-34. [DOI: 10.1089/scd.2019.0173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
105 Nardelli C, Granata I, Iaffaldano L, D'argenio V, Del Monaco V, Maruotti GM, Omodei D, Del Vecchio L, Martinelli P, Salvatore F, Guarracino MR, Sacchetti L, Pastore L. miR-138/miR-222 Overexpression Characterizes the miRNome of Amniotic Mesenchymal Stem Cells in Obesity. Stem Cells and Development 2017;26:4-14. [DOI: 10.1089/scd.2016.0127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
106 Shahani P, Datta I. Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much? Cytotherapy 2021:S1465-3249(21)00234-6. [PMID: 34053857 DOI: 10.1016/j.jcyt.2021.04.004] [Reference Citation Analysis]
107 Zhao L, Hu C, Han F, Chen D, Cheng J, Wu J, Peng W, Chen J. Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis. Stem Cell Res Ther 2021;12:158. [PMID: 33648596 DOI: 10.1186/s13287-021-02219-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Sarıkaya A, Aydın G, Özyüncü Ö, Şahin E, Uçkan-Çetinkaya D, Aerts-Kaya F. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.Biotech Histochem. 2021;1-11. [PMID: 33641543 DOI: 10.1080/10520295.2021.1885739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Grégoire C, Ritacco C, Hannon M, Seidel L, Delens L, Belle L, Dubois S, Vériter S, Lechanteur C, Briquet A, Servais S, Ehx G, Beguin Y, Baron F. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Front Immunol 2019;10:619. [PMID: 31001253 DOI: 10.3389/fimmu.2019.00619] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
110 Ramallo M, Carreras-Sánchez I, López-Fernández A, Vélez R, Aguirre M, Feldman S, Vives J. Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord. Histol Histopathol 2021;36:19-30. [PMID: 32914860 DOI: 10.14670/HH-18-249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Umezawa A, Hasegawa A, Inoue M, Tanuma-Takahashi A, Kajiwara K, Makino H, Chikazawa E, Okamoto A. Amnion-derived cells as a reliable resource for next-generation regenerative medicine. Placenta 2019;84:50-6. [PMID: 31272680 DOI: 10.1016/j.placenta.2019.06.381] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
112 Montanucci P, Pescara T, Alunno A, Bistoni O, Basta G, Calafiore R. Remission of hyperglycemia in spontaneously diabetic NOD mice upon transplant of microencapsulated human umbilical cord Wharton jelly‐derived mesenchymal stem cells (hUCMS). Xenotransplantation 2019;26:e12476. [DOI: 10.1111/xen.12476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ishaq M, Bandara N, Morgan S, Nowell C, Mehdi AM, Lyu R, McCarthy D, Anderson D, Creek DJ, Achen MG, Shayan R, Karnezis T. Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema. Int J Obes (Lond) 2021. [PMID: 34764426 DOI: 10.1038/s41366-021-01002-1] [Reference Citation Analysis]
114 Lopez-Santalla M, Bueren JA, Garin MI. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies. EBioMedicine 2021;69:103427. [PMID: 34161884 DOI: 10.1016/j.ebiom.2021.103427] [Reference Citation Analysis]
115 Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study. Drug Des Devel Ther 2019;13:4331-40. [PMID: 31908418 DOI: 10.2147/DDDT.S225613] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
116 Ramírez-Bajo MJ, Martín-Ramírez J, Bruno S, Pasquino C, Banon-Maneus E, Rovira J, Moya-Rull D, Lazo-Rodriguez M, Campistol JM, Camussi G, Diekmann F. Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity. Front Cell Dev Biol 2020;8:296. [PMID: 32432111 DOI: 10.3389/fcell.2020.00296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
117 Rovira J, Diekmann F, Campistol JM, Ramírez-bajo MJ. Therapeutic application of extracellular vesicles in acute and chronic renal injury. Nefrología (English Edition) 2017;37:126-37. [DOI: 10.1016/j.nefroe.2017.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
118 Piao C, Li Z, Ding J, Kong D. Mechanical properties of the sciatic nerve following combined transplantation of analytically extracted acellular allogeneic nerve and adipose-derived mesenchymal stem cells. Acta Cir Bras 2020;35:e202000405. [PMID: 32555937 DOI: 10.1590/s0102-865020200040000005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Cargnoni A, Papait A, Masserdotti A, Pasotti A, Stefani FR, Silini AR, Parolini O. Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy. Front Bioeng Biotechnol 2021;9:637737. [PMID: 33614619 DOI: 10.3389/fbioe.2021.637737] [Reference Citation Analysis]
120 Fracchiolla NS, Fattizzo B, Cortelezzi A. Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications. Stem Cells Int 2017;2017:6720594. [PMID: 28947904 DOI: 10.1155/2017/6720594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
121 Lv X, Wang L, Zou X, Huang S. Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges. Drug Des Devel Ther 2021;15:3927-36. [PMID: 34584402 DOI: 10.2147/DDDT.S323107] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P, Djalilian AR. Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells. 2018;36:775-784. [PMID: 29341332 DOI: 10.1002/stem.2781] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
123 Jensen AR, Manning MM, Khaneki S, Drucker NA, Markel TA. Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury. J Surg Res 2016;204:361-70. [PMID: 27565072 DOI: 10.1016/j.jss.2016.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
124 Zhuang X, Hu X, Zhang S, Li X, Yuan X, Wu Y. Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis. Clin Rev Allergy Immunol 2022. [PMID: 35031958 DOI: 10.1007/s12016-021-08892-z] [Reference Citation Analysis]
125 Nenasheva T, Nikolaev A, Diykanov D, Sukhanova A, Tcyganov E, Panteleev A, Bocharova I, Serdyuk Y, Nezlin L, Radaeva T, Adrianov N, Rubtsov Y, Lyadova I. The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice. PLoS One 2017;12:e0178983. [PMID: 28594940 DOI: 10.1371/journal.pone.0178983] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
126 Gebraad A, Kornilov R, Kaur S, Miettinen S, Haimi S, Peltoniemi H, Mannerström B, Seppänen-Kaijansinkko R. Monocyte-derived extracellular vesicles stimulate cytokine secretion and gene expression of matrix metalloproteinases by mesenchymal stem/stromal cells. FEBS J 2018;285:2337-59. [PMID: 29732732 DOI: 10.1111/febs.14485] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
127 Tavakoli S, Kisiel MA, Biedermann T, Klar AS. Immunomodulation of Skin Repair: Cell-Based Therapeutic Strategies for Skin Replacement (A Comprehensive Review). Biomedicines 2022;10:118. [DOI: 10.3390/biomedicines10010118] [Reference Citation Analysis]
128 Alfaifi M, Eom YW, Newsome PN, Baik SK. Mesenchymal stromal cell therapy for liver diseases. J Hepatol. 2018;68:1272-1285. [PMID: 29425678 DOI: 10.1016/j.jhep.2018.01.030] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 15.3] [Reference Citation Analysis]
129 Riis S, Stensballe A, Emmersen J, Pennisi CP, Birkelund S, Zachar V, Fink T. Mass spectrometry analysis of adipose-derived stem cells reveals a significant effect of hypoxia on pathways regulating extracellular matrix. Stem Cell Res Ther 2016;7:52. [PMID: 27075204 DOI: 10.1186/s13287-016-0310-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
130 Tsuji K, Ojima M, Otabe K, Horie M, Koga H, Sekiya I, Muneta T. Effects of Different Cell-Detaching Methods on the Viability and Cell Surface Antigen Expression of Synovial Mesenchymal Stem Cells. Cell Transplant 2017;26:1089-102. [PMID: 28139195 DOI: 10.3727/096368917X694831] [Cited by in Crossref: 55] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
131 Capelli C, Zaccara E, Cipriani P, Di Benedetto P, Maglione W, Andracco R, Di Luca G, Pignataro F, Giacomelli R, Introna M, Vitali C, Del Papa N. Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis. Cell Transplant. 2017;26:841-854. [PMID: 28139194 DOI: 10.3727/096368917x694822] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
132 Denu RA, Hematti P. Optimization of oxidative stress for mesenchymal stromal/stem cell engraftment, function and longevity. Free Radic Biol Med 2021;167:193-200. [PMID: 33677063 DOI: 10.1016/j.freeradbiomed.2021.02.042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Zdolińska-malinowska I, Boruczkowski D, Hołowaty D, Krajewski P, Snarski E, Mayani H. Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy. Stem Cells International 2022;2022:1-10. [DOI: 10.1155/2022/9125460] [Reference Citation Analysis]
134 Marupanthorn K, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Manochantr S. MicroRNA treatment modulates osteogenic differentiation potential of mesenchymal stem cells derived from human chorion and placenta. Sci Rep 2021;11:7670. [PMID: 33828198 DOI: 10.1038/s41598-021-87298-5] [Reference Citation Analysis]
135 Pogozhykh O, Prokopyuk V, Figueiredo C, Pogozhykh D. Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. Stem Cells Int 2018;2018:4837930. [PMID: 29535770 DOI: 10.1155/2018/4837930] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
136 Fiori A, Uhlig S, Klüter H, Bieback K. Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells. Cells 2021;10:E58. [PMID: 33401501 DOI: 10.3390/cells10010058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 García-Bernal D, García-Arranz M, Yáñez RM, Hervás-Salcedo R, Cortés A, Fernández-García M, Hernando-Rodríguez M, Quintana-Bustamante Ó, Bueren JA, García-Olmo D, Moraleda JM, Segovia JC, Zapata AG. The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy. Front Cell Dev Biol 2021;9:650664. [PMID: 33796536 DOI: 10.3389/fcell.2021.650664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
138 O'Reilly M, Thébaud B. Cell-based therapies for neonatal lung disease. Cell Tissue Res 2017;367:737-45. [PMID: 27770256 DOI: 10.1007/s00441-016-2517-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
139 Pombero A, Garcia-Lopez R, Martinez S. Brain mesenchymal stem cells: physiology and pathological implications. Dev Growth Differ 2016;58:469-80. [PMID: 27273235 DOI: 10.1111/dgd.12296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
140 Marrazzo P, Crupi AN, Alviano F, Teodori L, Bonsi L. Exploring the roles of MSCs in infections: focus on bacterial diseases. J Mol Med (Berl) 2019;97:437-50. [PMID: 30729280 DOI: 10.1007/s00109-019-01752-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
141 Horak J, Nalos L, Martinkova V, Tegl V, Vistejnova L, Kuncova J, Kohoutova M, Jarkovska D, Dolejsova M, Benes J, Stengl M, Matejovic M. Evaluation of Mesenchymal Stem Cell Therapy for Sepsis: A Randomized Controlled Porcine Study. Front Immunol 2020;11:126. [PMID: 32117276 DOI: 10.3389/fimmu.2020.00126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
142 Grau-Vorster M, Rodríguez L, Del Mazo-Barbara A, Mirabel C, Blanco M, Codinach M, Gómez SG, Querol S, García-López J, Vives J. Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly. Cells 2019;8:E484. [PMID: 31117301 DOI: 10.3390/cells8050484] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
143 Genç D, Günaydın B, Sezgin S, Aladağ A, Tarhan EF. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome. Immunotherapy 2022. [PMID: 35012368 DOI: 10.2217/imt-2021-0174] [Reference Citation Analysis]
144 Hadryś A, Sochanik A, McFadden G, Jazowiecka-Rakus J. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses. Eur J Pharmacol 2020;874:172991. [PMID: 32044323 DOI: 10.1016/j.ejphar.2020.172991] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
145 Villatoro AJ, Hermida-prieto M, Fernández V, Fariñas F, Alcoholado C, Rodríguez-garcía MI, Mariñas-pardo L, Becerra J. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety. Veterinary Record 2018;183:654-654. [DOI: 10.1136/vr.104867] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
146 Kilpinen L, Parmar A, Greco D, Korhonen M, Lehenkari P, Saavalainen P, Laitinen S. Expansion induced microRNA changes in bone marrow mesenchymal stromal cells reveals interplay between immune regulation and cell cycle. Aging (Albany NY) 2016;8:2799-813. [PMID: 27852979 DOI: 10.18632/aging.101088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
147 Cen S, Wang P, Xie Z, Yang R, Li J, Liu Z, Wang S, Wu X, Liu W, Li M, Tang S, Shen H, Wu Y. Autophagy enhances mesenchymal stem cell-mediated CD4+ T cell migration and differentiation through CXCL8 and TGF-β1. Stem Cell Res Ther 2019;10:265. [PMID: 31443687 DOI: 10.1186/s13287-019-1380-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]